The invention provides anti-Cyr61 protein monoclonal antibodies and preparation method thereof, and hybridoma cell strains used for producing said monoclonal antibodies. The invention also provides uses of the monoclonal antibodies for manufacturing medicaments for preventing or treating diseases related to proliferation, adhesion, migration or invasive growth of cells and uses for manufacturing reagents for detecting Cyr61 protein.